Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

The Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) is an invitation for proposals for a wide range of research projects related to computational genomics, data science, statistics and bioinformatics. These projects should have relevance to both basic and clinical genomic science and carry wide applications for human health and disease.

The funding opportunity primarily backs the development of innovative analytical methodologies and strategies in the field of genomics. This includes early-stage development of computational tools and software, improving, or 'hardening,' existing high-value software and tools used by the biomedical genomics community.

Additionally, the research work supported by this offering must contribute to the advancement of genomics and should be broad enough to be applicable across a spectrum of diseases and biological systems. Finally, it is essential for all submitted applications to demonstrate how their proposed methods are scalable to handle larger and increasingly complex data sets.